Introduction
Plexins (Plxns) are semaphorin (Sema) receptors that are highly expressed during development where SemaPlxn signaling plays important roles in nervous system, cardiac, vasculature, and bone development [1, 2] . At the cellular level, Sema-Plxn signaling regulates cytoskeletal dynamics, integrin-mediated adhesion, proliferation, differentiation, transcription, and programmed cell death [3] [4] [5] [6] [7] . With a wide array of functions, the signaling outcome of Semas depends on a variety of factors, including receptor subtype and the effector proteins associated with the cytosolic regions of both Plxns and transmembrane (TM) Semas [2, 8] . The intracellular signaling milieu in which Plxns and Semas act is highly dynamic and determined by differential protein expression driven by changing cell types and developmental timing [9] [10] [11] .
In mammals, there are nine Plxns classified into four subfamilies: PlxnA1-A4, B1-3, C1, and D1 [12] . PlexinA (PlxnA) family members, receptors for Sema3, Sema5, and Sema6 classes, are the most highly expressed Plxns throughout nervous system development, with PlxnA2 being the most highly expressed PlxnA in the cortical plate [12] [13] [14] [15] [16] [17] . Furthermore, PlxnA2 and the close family member PlxnA1 are also expressed in noncortical regions of the nervous system, including the retina [14, 18] . We have previously shown the importance for Sema6-PlxnA signaling in early vertebrate eye development, as decreasing PlxnA2 or semaphorin6A (Sema6A) in the zebrafish results in reduced retinal precursor cell (RPC) proliferation, loss of eye field cohesion, and impaired retinal lamination [7, 18] . Together, these results show that Sema6-PlxnA signaling initiates a variety of functional outcomes depending on cellular and organismal context.
Although the nature of Sema-Plxn binding has been well characterized [19, 20] , the receptor-proximal events that initiate specific functional outcomes of Sema-Plxn signaling are only partially understood. Plxn phosphorylation by tyrosine kinases is thought to be one way by which Plxns mediate intracellular signaling in response to Sema binding [21] . Receptor-type and cytoplasmic tyrosine kinases are known to associate with Plxn family members [16, [22] [23] [24] . In fact, there is evidence through large-scale proteomic screens that the intracellular domain of all nine Plxn family members can be tyrosine phosphorylated at least to some degree [25] . However, currently only PlxnB, based on mutagenesis studies, has been shown to be phosphorylated at specific sites by a specific kinase (ErbB2) [26] and to our knowledge no kinases have been identified to phosphorylate specific PlxnA tyrosine residues. Nonetheless, PlxnA receptors have been shown to be tyrosine phosphorylated when overexpressed in standard human cell lines [12] and the Src family tyrosine kinase (SFK) Fyn was later discovered to constitutively associate with and phosphorylate the intracellular region of PlxnA1 and PlxnA2 [22] . Furthermore, the cytosolic tyrosine kinase Fes has been shown to bind and phosphorylate PlxnA1 [23] , and the receptor tyrosine kinase (RTK) VEGFR2 has been shown to associate with PlxnA1 [16, 24] .
In spite of these known associations between tyrosine kinases and PlxnA receptors, no tyrosine phosphorylation sites have been identified to be regulated by specific tyrosine kinases. As Fyn has been implicated in PlxnA phosphorylation and is critical to Sema-induced dendritic maturation in cultured cortical neurons [22, 27] , we focused our study on Fyndependent PLXNA phosphorylation. To begin to elucidate the signaling role of tyrosine phosphorylation sites on Plxns, we set out to ascertain Fyn-dependent phosphorylation sites of PLXNA2 and PLXNA1. Using mass spectrometry and biochemical approaches, we have identified two novel Fyn-induced PLXNA phosphorylation sites that are conserved across vertebrates and invertebrates. Site-specific mutants of PLXNA2 and PLXNA1 verified that these tyrosine residues are the major sites of Fyn-dependent phosphorylation. Using zebrafish as a model organism, we investigated the in vivo functional significance of these sites and found that Fyn-dependent PlxnA2 phosphorylation is critical for zebrafish eye size. We end with a discussion on the possible signaling roles of these phosphorylation events at the molecular and cellular levels.
Results

Fyn induces PLXNA2 and PLXNA1 tyrosine phosphorylation
To recapitulate the Fyn-dependent PlxnA2 and PlxnA1 phosphorylation found by Sasaki et al., we first transfected HEK293 cells with expression plasmids encoding Flag-tagged PLXNA2 and either Fyn wild-type (WT) or a kinase dead (KD) point mutant of Fyn. PLXNA2 showed prominent tyrosine phosphorylation when Fyn WT was coexpressed and this phosphorylation was absent when Fyn KD was coexpressed (Fig. 1A) . Similarly, Flag-tagged PLXNA1 tyrosine phosphorylation was present when Fyn WT was coexpressed and absent when Fyn KD was coexpressed (Fig. 1B) . These results are consistent with the findings of others (Sasaki et al.) and demonstrate tyrosine phosphorylation events on PlxnA2 and PlxnA1 that are induced by Fyn kinase activity. To understand the molecular mechanisms of how PlxnA tyrosine phosphorylation might regulate PlxnA receptors, we next sought out to identify the tyrosine residues on PLXNA2 and PLXNA1 that are phosphorylated in a Fyn-dependent manner.
Bioinformatics reveals conserved tyrosine phosphorylation sites on PLXNA2 and PLXNA1
As an initial approach to identify potential Fyndependent tyrosine phosphorylation sites we asked if PlxnA family members were known to be tyrosine phosphorylated at specific sites as determined by largescale phosphoproteomic analyses. PhosphoSitePlus [25] is an online database that curates post-translational modification information, including phosphorylation, from both large-scale and site-specific studies. PhosphoSitePlus listed eight intracellular tyrosine residues found to be phosphorylated on PLXNA2 in large-scale proteomic screens. Seven out of these eight residues were found phosphorylated two or fewer times. However, Y1605 has been found phosphorylated in 20 independent proteomic screens ( Fig. 2A) . This site is conserved across vertebrates and invertebrates as well as within PLXNA1 (Fig. 2B ). Indeed, PhosphoSitePlus shows nine intracellular tyrosine residues to be phosphorylated on PLXNA1, with eight of these sites only being found to be phosphorylated once ( Fig. 2A) . However, Y1608 in PLXNA1 is homologous to PLXNA2 Y1605 and has been found to be phosphorylated 58 independent times. These data suggest there may be an evolutionarily conserved role for this phosphorylation event in PlxnA signaling. Importantly, the kinase that phosphorylates this site has not been identified and we hypothesized that Fyn could be the tyrosine kinase responsible for phosphorylating PlxnA2 and PlxnA1 on Y1605 and Y1608, respectively.
Targeted mass spectrometry finds Y1605 as a Fyn-dependent phosphorylation site on PLXNA2
To determine if Fyn phosphorylates PLXNA2 at Y1605, we made use of synthetic, stable isotopecontaining peptides harboring phosphorylated and unphosphorylated Y1605 as references to determine the expected elution time of the native PLXNA2 peptides as well as their MS2 spectral patterns. HEK293 cells were transfected with expression plasmids encoding PLXNA2 WT-Flag alone or with either Fyn WT or Fyn KD. PLXNA2 was then immunopurified from extracts of each group. A portion of each immunoprecipitation was used for immunoblotting to confirm PLXNA2 expression and to confirm Fyninduced PLXNA2 tyrosine phosphorylation (Fig. 3A) . The majority of each immunoprecipitation was subjected to SDS/PAGE and coomassie staining (Fig. 3B) . From these gels, the control and PLXNA2 bands running at approximately 200 kDa were excised and subjected to in-gel tryptic digestion. Extracted peptides were supplemented with unphosphorylated and phosphorylated Y1605-containing peptides (QTSSYNIPA-SASISR) containing 13 C 5 -and 15 N-labeled proline. A targeted approach was used to trigger MS/MS scans on the m/z values of the doubly charged precursor ions for the native tryptic peptides of PLXNA2 containing unphosphorylated and phosphorylated Y1605. Using the synthetic stable isotope-containing peptides as a reference allowed us to readily detect the phosphorylated and unphosphorylated Y1605-containing PLXNA2 tryptic peptides (the MS2 spectral pattern of the phosphorylated synthetic peptide is shown in Fig. 3C ). The unphosphorylated peptide was found across treatment groups. However, the phosphorylated Y1605 PLXNA2 peptide was only detected in cells expressing both PLXNA2 and Fyn WT (Fig. 3D) . This supports the hypothesis that active Fyn can induce phosphorylation of PLXNA2 at Y1605 in cells.
A SILAC mass spectrometry approach identifies Y1677 as a novel Fyn-dependent phosphorylation site on PLXNA2
To ascertain if additional Fyn-dependent PLXNA2 phosphorylation sites could be identified, we used stable isotope labeling of amino acids in cell culture (SILAC), a proteomics approach that utilizes cells grown in media containing heavy-labeled amino acids [28] . The advantage of a quantitative labeling method such as SILAC is that it allows different treatment types to be combined and handled equally in the preparation of peptides for LC-MS/MS. HEK293 cells expressing PLXNA2 WT-Flag and Fyn WT were grown in Dulbecco's modified Eagle's medium (DMEM) containing no heavy-labeled amino acids (Light condition, Fig. 4A ). Cells expressing PLXNA2 WT-Flag and Fyn KD were grown in DMEM containing 13 C-and 15 N-labeled arginine and lysine (Heavy condition), resulting in newly synthesized proteins incorporating heavy labels. PLXNA2 was Immune complexes and whole cell extracts were subjected to SDS/PAGE and immunoblotting with the indicated antibodies.
immunoprecipitated using a-Flag resin and both PLXNA2 groups were combined and loaded onto a SDS/PAGE gel and stained with coomassie dye (Fig. 4B) . The PLXNA2 band as well as the untransfected control band were cut and prepared for mass spectrometry analysis.
Following a SEQUEST search and an automated calculation of the heavy : light ratio [29] of PLXNA2 peptides, we determined the distribution of all PLXNA2 fully tryptic peptides identified which covered amino acid sequences for which we did not find a phosphorylation event. As the relative abundance of these peptides was not likely altered by the treatment, they would define the relative amount of PLXNA2 immunoprecipitated from the two conditions. The average heavy : light ratio for the 71 peptide pairs we identified was 2.9 with a standard deviation of 0.5. This indicated that in this experiment the amount of PLXNA2 immunoprecipitated from the heavy state with Fyn KD expressed was nearly three times the amount immunoprecipitated from the light state with Fyn WT expressed. Only one phosphotyrosine-containing peptide was identified in our analysis and, importantly, it was found only in the light state. Surprisingly, we did not identify phosphotyrosyl-1605 in the SILAC analysis. The identified phosphopeptide contained tyrosine phosphorylation at Y1677. The stoichiometry of phosphorylation at Y1677 can be inferred by the decrease in the unphosphorylated form of this peptide relative to the average SILAC ratio. The SILAC ratio of the unphosphorylated form is approximately 15% less when Fyn WT is coexpressed compared to the mean SILAC ratio of PLXNA2 peptides suggesting 15% phosphorylation at that site (Fig. 4C ). As the precursor ion for the phosphopeptide was not observable in the heavy state, a signal-to-noise (S/N) calculation was used to approximate its minimum fold increase. While the total amount of the phosphopeptide might in fact be zero, the S/N calculation describes the lowest possible observable signal and serves as a baseline for the minimum fold increase. The lowest possible signal is a peptide ion in the full MS1 mass spectrum with an observable isotopic envelope as compared to surrounding noise peaks which do not have observable isotopic envelopes and therefore are considered noise from the solvent alone. In this case the signal of the observed light phosphopeptide was 9.4 times the noise. Given that less light PLXNA2 was immunoprecipitated compared to heavy PLXNA2, the total fold increase of this phosphopeptide induced by Fyn WT was even greater.
Interestingly, a multiple species alignment indicates that Y1677 is conserved between PlxnA2 and PlxnA1 across species, including vertebrates and invertebrates (Fig. 3E) . Indeed, this tyrosine residue is in a highly conserved region of the cytoplasmic domain across all Plxn family members [21] , which may point to an evolutionarily important function.
Y1605 and Y1677 are the major Fyn-dependent sites of PLXNA2 tyrosine phosphorylation
To determine if Y1605 and Y1677 were the major sites of Fyn-dependent PLXNA2 tyrosine phosphorylation, we made single and double tyrosine-to-phenylalanine The majority of the immune complexes for each sample was subjected to SDS/PAGE and protein bands were visualized by coomassie staining. The regions of the gel where PLXNA2 bands run were excised and digested with trypsin and the tryptic peptides were prepared for mass spectrometry. Unphosphorylated and phosphorylated Y1605-containing synthetic reference peptides with a 13 C 5 -and 15 N-labeled proline (P*) were added to the native extracted peptides. A targeted approach was used to subject the appropriate m/z values of the doubly charged tryptic peptides containing either the unphosphorylated or phosphorylated Y1605 to CID in a LTQ-Orbitrap mass spectrometer. (C,D) The unphosphorylated native PLXNA2 peptide containing Y1605 was found across treatment groups, but the phosphorylated native peptide was only found in the PLXNA2 + Fyn WT group. Shown are the MS/MS spectra of the phosphorylated Y1605 synthetic peptide (C) and the Y1605 phosphorylated native peptide (D). (Fig. 5A, quantified in Fig. 5C ). However, some Fyndependent tyrosine phosphorylation remained on the Y2F mutant suggesting the presence of at least one additional Fyn-dependent tyrosine phosphorylation site on PLXNA2. To determine the predominant Fyninduced PLXNA2 phosphorylation site, the single point mutants were coexpressed in HEK293 cells with Fyn WT. We found that Fyn-induced tyrosine phosphorylation was reduced for both Y1605F and Y1677F mutants (Fig. 5B, quantified in Fig. 5C ). Interestingly, each PLXNA2 mutant appeared to decrease in tyrosine phosphorylation signal equally, suggesting Fyn shows roughly equal preference for phosphorylating Y1605 and Y1677.
Fyn-dependent phosphorylation sites are conserved between PLXNA1 and PLXNA2
To ascertain if Fyn phosphorylates PLXNA1 at sites homologous to those identified on PLXNA2, we cotransfected HEK293 cells with expression plasmids encoding Fyn WT and either PLXNA1 WT-Flag or PLXNA1 Y2F-Flag. The Y2F allele of PLXNA1 has tyrosine-to-phenylalanine substitutions at Y1608 and Y1679, the sites homologous to Y1605 and Y1677 in PLXNA2. As hypothesized, PLXNA1 tyrosine phosphorylation decreased significantly when both Y1608 and Y1679 were unable to be phosphorylated (Fig. 6A, quantified in Fig. 6B ). In fact, it appears that the combination of Y1608 and Y1679 constitutes almost all of the Fyn-dependent tyrosine phosphorylation on PLXNA1 (Fig. 6A) .
Fyn-dependent PlxnA2 phosphorylation sites are critical for Zebrafish eye development
To investigate the functional importance of in vivo PlxnA2 phosphorylation, we turned to the zebrafish model as we have previously characterized the function of PlxnA2 in zebrafish eye development [7, 18] . PlxnA2 is expressed in the retina and is critical to zebrafish eye development, as decreasing endogenous PlxnA2 using a morpholino antisense oligonucleotide (MO) targeted to plxnA2 results in decreased proliferation of RPCs, loss of RPC cohesion within migrating optic vesicles, impaired retinal lamination, and decreased eye size [7, 18] . Importantly, these phenotypes are rescued by coinjecting the plxnA2 MO with human PLXNA2-WT mRNA at the one-cell stage of development, supporting the evolutionary conservation of PlxnA2 among vertebrates [7, 18] . The plxnA2 MO construct used has been previously validated to address knockdown specificity and any potential off-target effect [7, 18] . If PlxnA phosphorylation is critical to Sema6A signaling and vertebrate eye development, we hypothesized that the plxnA2 morphant phenotypes would not be rescued upon coinjection of plxnA2 MO with human PLXNA2 Y2F mRNA. Indeed, while coinjecting plxnA2 MO with PLXNA2 WT mRNA rescued the small eye phenotype at 48 hours post fertilization (hpf), coinjection of PLXNA2 Y2F mRNA did not (Fig. 7A-D) . To control for any variations in overall embryo size, we normalized eye diameter to head length (quantified in Fig. 7G ). Furthermore, overexpression of human PLXNA2 WT or Y2F mRNA resulted in no obvious phenotype, nor was eye size significantly different than uninjected controls (UIC; Fig. 7E-F ; quantified in 7G). As it was formally possible that PLXNA2 Y2F did not rescue the plxnA2 MO phenotype due to improper subcellular localization, we conducted immunofluorescence on HEK293, COS7, and NIE-115 cells expressing PLXNA2 WT and Y2F (Fig. 7H-O ). HEK293 and COS7 cells were relevant given they have been used to investigate PlxnA2 signaling in biochemical and cell-based assays [12, 15, 19, 20] . COS7 cells are heterogeneous and we focused here on cells with extended processes as SemaPlxnA signaling is known to localize to neuronal processes and to regulate axon and dendrite guidance [12, [30] [31] [32] . NIE-115 is a heterogeneous cell line that is responsive to semaphorins, as Sema3A stimulation results in neurite retraction [33] . We show immunofluorescence of PLXNA2 WT and Y2F expressed in NIE-115 cells displaying long processes (Fig. 7L,M) as well as numerous short processes (Fig. 7N,O) . In all cases PLXNA2 WT and Y2F appeared to have similar subcellular expression patterns (Fig. 7H-O) , suggesting that the Y2F mutation did not affect protein localization. Together, these results suggest that the Fyndependent PlxnA phosphorylation sites identified in this study have important, conserved in vivo functions.
Discussion
Here we show that Fyn induces the phosphorylation of two conserved sites on PLXNA1 and PLXNA2. Mechanistically, PlxnA tyrosine phosphorylation by SFKs could, via structural alterations, modulate the GAP activity of the receptors as the conserved sites of tyrosine phosphorylation are in or near the split GAP domain of the PlxnA receptors [34] . Additionally, PlxnA tyrosine phosphorylation could be involved in recruiting effectors of signal transduction. Tyrosine phosphorylation can regulate protein-protein interactions by providing docking sites for SH2 or PTB domain-containing proteins. Precedence for these signaling mechanisms have been established in Sema-Plxn signaling with Sema4D-induced tyrosine phosphorylation of PlxnB1 leading to the recruitment of the p85 subunit of PI3K and subsequent Akt activation. Stimulation of this signaling axis in endothelial cells was shown to promote endothelial migration [35] . While PI3K is not predicted to bind to PLXNA1 and PLXNA2, a Scansite [36] analysis of the intracellular domains predicts a possible function for one of the two sites we have identified here. Scansite suggests that PLXNA2 Y1605 phosphorylation could provide a binding site for the SH2 domain of the adaptor molecule Crk, or its relative CrkL, which preferentially bind to phosphorylated YXXP motifs [37] . The Rap1-GEF C3G binds to the SH3 domain of Crk and CrkL, and is involved in many cellular processes including cell-cell interactions, integrin-mediated adhesion, and differentiation [38] . Thus, Crk and CrkL binding to phosphorylated PlxnA2 could mediate some of the individual roles of Sema signaling. In spite of the fact that SFKs themselves harbor the name-sake SH2 domain, they do not appear to use their SH2 domains to bind to PlxnA receptors as Fyn has been reported to be constitutively bound to PlxnA2 independent of Fyn's kinase activity, and by extension, the tyrosine phosphorylation state of PlxnA2 [22] . Future work will work to identify the proteins that bind to PLXNA proteins at the Fyn-induced phosphorylation sites. Although the mechanisms downstream of these phosphorylation sites are unknown, the identification of Fyn-dependent PlxnA phosphorylation sites has been anticipated for some time [21] . Here, we have identified the two predominant sites and have found them to be functionally relevant to PlxnA signaling, setting the stage for future steps in delineating the role of tyrosine phosphorylation in PlxnA signaling pathways.
Materials and methods
Bioinformatics and multiple sequence alignments
Previously reported human PLXNA2 and PLXNA1 tyrosine phosphorylation from large-scale proteomic screens was collected from PhosphoSitePlus [25] 
Plasmids, cell culture, and transfections
The human PLXNA2 construct (Origene Technologies, Rockville, MD, USA) harbored human PLXNA2 (NP_079455) containing a C-terminal Myc and Flag tag in pCMV6-Entry. The cloning sites were SgfI and MluI. BioBasic (Markham, Ontario, Canada) produced the single and double point mutant PLXNA2 constructs: Y1605F, Y1677F, and Y1605F/Y1677F. BioBasic also synthesized human PLXNA1-WT and PLXNA1-Y1608F/Y1679F (Y2F) containing a C-terminal Myc and Flag tag and cloned them into the vector pUC57. BioBasic cloned PLXNA1-WT into pCMV6-Entry vector using SgfI and MluI. To develop a pCMV6-PLXNA1-Y2F construct, we used MluI and BssHII (New England Biolabs, Ipswich, MA, USA) to subclone a portion of PLXNA1 containing Y1608F/Y1679F from pUC57-PLXNA1-Y2F into pCMV6-Entry-PLXNA1-WT. Human Fyn-WT (plasmid #16032) and KD mutant L299M Fyn (plasmid #16033) constructs were purchased from Addgene (Cambridge, MA, USA), which were originally cloned into pRK5 and deposited by F. Giancotti [40] . HEK293 cells were maintained in DMEM with L-glutamine, 4.5 gÁL À1 glucose and sodium pyruvate (MediaTech/Corning Life Sciences, Tewksbury, MA, USA) supplemented with 5% FBS (Hyclone, Logan, UT, USA), 5% Cosmic Calf Serum (Hyclone), 50 unitsÁmL À1 penicillin and 50 lgÁmL À1 streptomycin (Invitrogen, Carlsbad, CA, USA) at 37°C and 5.0% CO 2 . Calcium phosphate-based transfections were conducted on cells grown to 75% of confluence. Following a 6-h incubation, the cells were washed with warm PBS and incubated for an additional 18-20 h in full medium prior to lysis.
Cell lysis, immunoprecipitation, and Western blotting
After transfection, cells were placed on ice, washed with cold PBS, and lysed in lysis buffer (25 mM Tris pH 7.4, 137 mM NaCl, 10% glycerol, 1% Igepal) containing protease inhibitors (5 lgÁmL À1 pepstatin, 10 lgÁmL À1 leupeptin, 1 mM PMSF) and phosphatase inhibitors (1 mM NaVO 3 , 25 mM NaF, 10 mM Na 2 H 2 P 2 O 7 ). Cell extracts were prepared for SDS/PAGE, immunoblotting, and immunoprecipitation as previously described [41] . A Bradford assay [42] was performed to determine protein concentration and extracts were normalized with lysis buffer. Depending on the experiment, between 20 and 30 lg of total protein extract was used for immunoblotting. Depending on the experiment, between 750 and 1000 lg total protein was used for immunoprecipitations and was incubated overnight at 4°C with 10 lL of a 50% slurry of a-Flag M2 affinity resin (Sigma-Aldrich Corp., St. Louis, MO, USA) prewashed with lysis buffer. Immune complexes were washed three times with lysis buffer, drained, and then denatured in protein sample buffer at 95°C for 5 min prior to SDS/PAGE separation. The following primary antibodies and dilutions were used: a-Fyn (rabbit mAb, 1 : 2000; Cell Signaling Technology), a-Flag M2 (mouse mAb, 1 : 2000; Sigma-Aldrich Corp.), a-phosphotyrosine 4G10 (mouse mAb; 1 : 1000; EMD Millipore, Billerica, MA, USA), and a-Src pY416 (rabbit mAb, 1 : 5000; Cell Signaling Technology). The following secondary antibodies were used: a-rabbit-HRP (goat IgG, 1 : 15 000; EMD Millipore), a-mouse-HRP (goat IgG, 1 : 5000; EMD Millipore), or for immunoprecipitation samples, a-mouse-HRP Light Chain Specific (goat IgG, 1 : 10 000, Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Immunoblotting was performed as described previously [41] .
Enhanced chemiluminescence, densitometry analysis, and statistics
Proteins from western blotting were detected using enhanced chemiluminescence (ThermoFisher Scientific, Waltham, MA, USA) and film was developed using a Medical Film Processor SRX-101A (Konica Minolta Medical & Graphic, Tokyo, Japan). The raw film scans were converted to grayscale and inverted in Adobe Photoshop for densitometry analysis using the mean histogram tool. The background ('untransfected control' group) signal was subtracted from all bands and the tyrosine phosphorylated PLXNA2 or A1 (as measured by a-phosphotyrosine 4G10) levels were made relative to PLXNA2 or A1 + Fyn WT in each experiment by setting this value as 100%. Total PLXNA2 or A1 protein levels were made relative in a similar fashion using a-Flag M2 lanes. Relative a-phosphotyrosine 4G10 levels were then divided by the relative a-Flag M2 levels to calculate the PLXNA2 or A1 tyrosine phosphorylation per sample type. To account for relative Fyn activity, a-phosphotyrosine (4G10) or a-Src pY416 levels for Fyn (as a proxy for kinase activity) were made relative with the levels in the cotransfected Fyn with PLXNA1 or PLXNA2 WT set as 100% in each experiment. The relative PLXNA2 or A1 tyrosine phosphorylation levels were then divided by the relative levels of phosphotyrosyl-Fyn to calculate the final relative tyrosine phosphorylation levels of PLXNA2 or A1. These values were then Log2 transformed and a Student's T-test pair-wise comparison was performed on the data from three independent experiments using JMP PRO 12 Statistical Software (SAS Institute, Cary, NC, USA).
Sample preparation for mass spectrometry and mass spectrometry data analysis HEK293 cells either untransfected or expressing PLXNA2-WT-Flag and either Fyn WT or Fyn KD were lysed and extracts were subjected to immunoprecipitation with a-Flag M2 affinity resin as described above. Samples were loaded onto 10% SDS/PAGE gels and proteins were visualized using coomassie stain (0.1% coomassie brilliant blue R-250, 20% glacial acetic acid, 40% methanol). The gel region containing the visible PLXNA2-Flag band and corresponding to approximately 200 kDa was cut out, diced, and prepared for tryptic digestion as previously described [43] with the reduction and alkylation steps being omitted.
Proteins were subjected to in-gel digestion with 6 ngÁlL À1 sequencing-grade modified trypsin (Promega, Madison, WI, USA) in 50 mM ammonium bicarbonate at 37°C for 6-9 h. The tryptic peptides were resuspended in Solvent A (2.5% acetonitrile, 0.15% formic acid) and separated via HPLC prior to MS/MS analysis on a linear ion traporbitrap (LTQ-Orbitrap) mass spectrometer controlled with Thermo XCALIBUR 2.1 software (Waltham, MA, USA). Peptides were loaded onto 15 cm 9 100 lm columns packed with 5 lm C18 packing material (Bruker Daltonics, Billerica, MA, USA, pore size = 200 A) over 15 min in Solvent A and eluted using a 0-50% gradient of Solvent B (99.85% acetonitrile, 0.15% formic acid) over 38 min and electrosprayed (2.1 kV) into the mass spectrometer. This gradient was followed by 3 min of a 50-100% gradient of Solvent B. This was followed by 4 min at 100% Solvent B before a 10-min equilibration in 100% Solvent A. The precursor scan (scan range = 360-1700 m/z, resolution = 3.0 9 10 4 , scan speed = 0.3 Hz) was followed by four collisioninduced dissociation (CID) tandem mass spectra. CID spectra were acquired for the top two ions in the precursor scan (isolation window = AE 2.0 m/z, collision energy = 35 eV), followed by two targeted scans. The targeted scans targeted the average mass (AE 1.6 m/z) of the doubly charged tryptic peptide ions harboring: (a) the unphosphorylated PLXNA2 ('heavy condition') as previously described [44] . These cells were transfected as described above with expression plasmids encoding PLXNA2 WT-Flag and Fyn KD. HEK293 cells grown in DMEM containing no heavy-labeled amino acids ('light condition') were transfected with expression plasmids encoding PLXNA2 WT-Flag and Fyn WT. Following lysis, PLXNA2-Flag was immunoprecipitated from each cell state using a-Flag resin. Immune complexes from the two states were combined and subjected to SDS/PAGE. The coomassie-stained PLXNA2 band and the corresponding control derived from untransfected cells were cut and prepared for mass spectrometry analysis as detailed above. Peptides were subjected to LC-MS/MS in a LTQ-Orbitrap run as previously described [45] . SEQUEST search parameters allowed a precursor ion mass tolerance of 30 p.p.m., required peptides to be tryptic and allowed for the same amino acid modifications as described above with the addition of arginine (+ 10.008 for the heavy label) and lysine (+ 8.014 for the heavy label). Following an automated calculation of the heavy : light ratio [29] , the average heavy : light fold change was calculated from unphosphorylated peptides that were fully tryptic and contained no internal arginines or lysines.
Immunofluorescence in cell culture
HEK293 cells were transfected in 6 cm dishes at 75% of confluence with 0.25 lg of either PLXNA2-WT-Flag or PLXNA2-Y2F-Flag using calcium phosphate precipitation as previously described [46] . COS7 cells were seeded onto glass coverslips in six-well plates and transfected at 20% of confluence using polyethylenimine [47] and incubated at 37°C and 5.0% CO 2 for 48 h. NIE-115 cells were seeded onto poly-L-lysine treated coverslips and transfected at 90% of confluence with Lipofectamine 2000 (ThermoFisher Scientific). Both COS7 and NIE-115 cells were transfected with 2 lg of either PLXNA2-WT-Flag or PLXNA2-Y2F-Flag and incubated at 37°C and 5.0% CO 2 for 48 h. HEK293, NIE-115, and COS7 cells were then processed for immunofluorescence as previously described [46] . The primary antibody was incubated at room temperature for 1 h in a humidified chamber: a-Flag M2 (mouse mAb, 1 : 5000; Sigma-Aldrich) in 1.5% BSA in PBS. The secondary antibody was incubated for 45 min at 4°C in a humidified chamber: a-mouse Alexa Fluor 488 (1 : 10 000, Molecular Probes/Invitrogen, Eugene, OR, USA). Coverslips were mounted onto microscope slides using VectaShield Hardset mounting media with DAPI (Vector Laboratories, Burlingame, CA, USA). Cells were imaged at 409 magnification using a Nikon Eclipse Ti inverted confocal microscope (Nikon Instruments, Melville, NY, USA). Raw image files were converted to TIFs using IMAGEJ version 1.48a (National Institutes of Health, Bethesda, MA, USA) and color processing was done in Adobe Photoshop CS6 (San Jose, CA, USA).
Zebrafish husbandry, morpholino, and mRNA rescue experiments
Zebrafish embryos were developmentally staged as previously described [48] . The zebrafish used in this study (isl2b: GFP transgenic line) were generously provided by Chien (University of Utah, USA). All procedures were approved by the University of Vermont Institutional Animal Care and Use Committee (IACUC). For MO injections, 2 ng of a splice-blocking MO (Gene Tools, Philomath, OR, USA) targeting plxnA2 and/or 200 pg of full-length human PLXNA2 or PLXNA2 Y2F mRNA was injected at the one-cell stage as previously described [7] . The plxnA2 MO sequence was as follows: AAAAGCGATGTCTTTCTCACCTTCC, which targeted the exon 2-intron 2 boundary. The plxnA2 MO knockdown efficiency has been previously validated using RT-PCR, and off-target effects and MO specificity have been addressed by rescue of morphant phenotypes with full-length human PLXNA2 mRNA and coinjection of plxnA2 and p53 MOs [7, 18] . A second nonoverlapping MO construct reproduced the same phenotypes [18] . Capped and tailed fulllength mRNA was generated from the pCMV6-Entry-PLXNA2-WT and -Y2F plasmids by linearizing the plasmids using PmeI (New England Biolabs), T7 RNA polymerase (mMESSAGE mMACHINE kit; Ambion, Austin, TX, USA), and the ThermoFisher PolyA Tailing Kit. These constructs were injected or coinjected with MO into zebrafish embryos at the one-cell stage [48] . Zebrafish embryos were incubated at 28.5°C for 2 days until the 48 hpf stage [48] . Measurements and bright-field images taken at 6.39 magnification were obtained using SPOT imaging software version 5.2 (Sterling Heights, MI, USA). To account for any variations in overall embryo size, eye size was calculated as eye diameter normalized to head size, which was defined as the distance from the anterior tip of the head to the posterior otic placode [7] . Figures were compiled using Adobe Photoshop CS6, where image brightness was optimized. Graphs and statistical analyses were obtained using PRISM 6 (GraphPad Software, La Jolla, CA, USA).
